Lista de obras - Larisa Rudenko - Dominio Público Uruguay

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

artículo científico publicado en 2020

A promising inactivated whole-virion SARS-CoV-2 vaccine

artículo científico publicado en 2020

Animal cloning and the FDA--the risk assessment paradigm under public scrutiny

artículo científico publicado en 2007

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

artículo científico publicado en 2014

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.

artículo científico publicado en 2015

B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method

artículo científico publicado en 2011

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

article

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.

artículo científico publicado en 2018

COVID-19 in Light of Seasonal Respiratory Infections

artículo científico publicado en 2020

Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.

artículo científico publicado en 2004

Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.

artículo científico publicado en 2014

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.

artículo científico publicado en 2015

Cold-adapted influenza viruses as a promising platform for viral-vector vaccines.

artículo científico publicado en 2016

Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets

artículo científico publicado en 2011

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

artículo científico publicado en 2011

Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model

artículo científico publicado en 2016

Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method

artículo científico publicado en 2009

Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium

artículo científico publicado en 2012

Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell res

artículo científico publicado en 2020

Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens

artículo científico publicado en 2020

Contribution of neuraminidase of influenza viruses to the sensitivity to sera inhibitors and reassortment efficiency

artículo científico publicado en 2014

Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships

artículo científico publicado en 2007

Core commitments for field trials of gene drive organisms

artículo científico publicado en 2020

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets

artículo científico publicado en 2018

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine

artículo científico publicado en 2014

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

artículo científico publicado en 2006

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

artículo científico publicado en 2016

Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

artículo científico publicado en 2014

Development of a copper database for exposure-response analysis

artículo científico publicado en 2010

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

artículo científico publicado en 2014

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

artículo científico publicado en 1993

Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets

artículo científico publicado en 2011

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

artículo científico publicado en 2019

Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets

artículo científico publicado en 2016

Food consumption risks associated with animal clones: what should be investigated?

scientific article published on 01 January 2004

Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes

artículo científico publicado en 2020

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

artículo científico publicado en 2011

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.

artículo científico publicado en 2015

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine

artículo científico publicado en 2017

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

artículo científico publicado en 2015

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus

artículo científico publicado en 2013

H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets

artículo científico publicado en 2016

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

artículo científico publicado en 2015

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

artículo científico publicado en 2013

Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination

artículo científico publicado en 2008

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.

artículo científico publicado en 2017

Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh

artículo científico publicado en 2018

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses

artículo científico publicado en 2015

Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines

artículo científico publicado en 2020

Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.

artículo científico publicado en 2006

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

artículo científico publicado en 2014

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza

artículo científico publicado en 2017

Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site

article

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

artículo científico publicado en 2011

M2e-based universal influenza vaccines: a historical overview and new approaches to development

artículo científico publicado en 2019

Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.

artículo científico

Oral influenza vaccination-a possible solution for the next pandemic?

artículo científico publicado en 2020

Overview of human rhinovirus immunogenic epitopes for rational vaccine design

scientific article published on 21 August 2019

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus

article

Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus

artículo científico publicado en 2015

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

artículo científico publicado en 2004

Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus

artículo científico publicado en 2010

Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains

artículo científico publicado en 2012

Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus

artículo científico publicado en 2020

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

artículo científico publicado en 2004

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

artículo científico publicado en 2018

Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?

artículo científico publicado en 2016

Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections

scientific article published on 24 April 2020

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

scientific article published on 07 May 2019

Regulation of xenogeneic porcine pancreatic islets ⬇️

artículo científico publicado el 1 de septiembre de 2010

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

artículo científico publicado en 2015

Rules of the road for insect gene drive research and testing

artículo científico publicado en 2017

Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.

artículo científico publicado en 2014

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2017

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).

artículo científico publicado en 2008

Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.

artículo científico publicado en 2015

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge

scientific article published on 08 July 2019

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.

artículo científico publicado en 2015

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines

artículo científico publicado en 2020

Tackling a novel lethal virus: a focus on H7N9 vaccine development.

artículo científico publicado en 2017

The US FDA and animal cloning: risk and regulatory approach

artículo científico publicado en 2006

The effect of pre-existing immunity on virus detection and immune responses in a phase II randomized trial of a Russian-backbone live attenuated influenza vaccine in Bangladeshi children

article

Two Live Attenuated Vaccines against Recent Low⁻and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets

scientific article published on 01 November 2018

Will there ever be a new influenza pandemic and are we prepared?

artículo científico publicado en 2015

Lista de obras de Larisa Rudenko

A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

A promising inactivated whole-virion SARS-CoV-2 vaccine

Animal cloning and the FDA--the risk assessment paradigm under public scrutiny

Assessment of human immune responses to H7 avian influenza virus of pandemic potential: results from a placebo-controlled, randomized double-blind phase I study of live attenuated H7N3 influenza vaccine.

Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.

B- and T-cell memory elicited by a seasonal live attenuated reassortant influenza vaccine: assessment of local antibody avidity and virus-specific memory T-cells using trogocytosis-based method

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.

COVID-19 in Light of Seasonal Respiratory Infections

Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses.

Characterization of reverse genetics-derived cold-adapted master donor virus A/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model.

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study.

Cold-adapted influenza viruses as a promising platform for viral-vector vaccines.

Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets

Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine).

Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model

Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method

Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium

Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell res

Construction and Immunogenicity of a Novel Multivalent Vaccine Prototype Based on Conserved Influenza Virus Antigens

Contribution of neuraminidase of influenza viruses to the sensitivity to sera inhibitors and reassortment efficiency

Copper and human health: biochemistry, genetics, and strategies for modeling dose-response relationships

Core commitments for field trials of gene drive organisms

Cross-Protective Efficacy of Monovalent Live Influenza B Vaccines against Genetically Different Lineages of B/Victoria and B/Yamagata in Ferrets

Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories.

Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus.

Development of a copper database for exposure-response analysis

Development of one-step real-time PCR assay for titrating trivalent live attenuated influenza vaccines

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets

Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets

Food consumption risks associated with animal clones: what should be investigated?

Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.

Genotyping assay for differentiation of wild-type and vaccine viruses in subjects immunized with live attenuated influenza vaccine

H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers.

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus

H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial.

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?

Immunization with live influenza viruses in an experimental model of allergic bronchial asthma: infection and vaccination

Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein.

Immunogenicity and viral shedding of Russian-backbone seasonal trivalent, live-attenuated influenza vaccine in a phase II randomized placebo-controlled trial among pre-school aged children in urban Bangladesh

Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses

Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines

Interferon and other proinflamatory cytokine responses in vitro following infection with wild-type and cold-adapted reassortant influenza viruses.

Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.

Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza

Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site

Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.

M2e-based universal influenza vaccines: a historical overview and new approaches to development

Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine.

Oral influenza vaccination-a possible solution for the next pandemic?

Overview of human rhinovirus immunogenic epitopes for rational vaccine design

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus

Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

Phenotypic characteristics of novel swine-origin influenza A/California/07/2009 (H1N1) virus

Possible outcomes of reassortment in vivo between wild type and live attenuated influenza vaccine strains

Prospects of and Barriers to the Development of Epitope-Based Vaccines against Human Metapneumovirus

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model

Reassortant viruses for influenza vaccines: is it time to reconsider their genome structures?

Recombinant Live Attenuated Influenza Vaccine Viruses Carrying Conserved T-cell Epitopes of Human Adenoviruses Induce Functional Cytotoxic T-Cell Responses and Protect Mice against Both Infections

Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease

Regulation of xenogeneic porcine pancreatic islets ⬇️

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

Rules of the road for insect gene drive research and testing

Safety and immunogenicity in man of a cell culture derived trivalent live attenuated seasonal influenza vaccine: a Phase I dose escalating study in healthy volunteers.

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial

Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).

Safety, immunogenicity and infectivity of new live attenuated influenza vaccines.

Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge

Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.

Study of Neuraminidase-Inhibiting Antibodies in Clinical Trials of Live Influenza Vaccines